Intrinsiqq
Sintx Technologies Inc. logo

Sintx Technologies Inc. Insider Trading

SINT

⊜ Compare
Last 12 months

Insiders bought 358K on the open market and sold nothing.

Net open-market
+358K
6 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
4 / 0
executives and directors
Last open-market buy
Mar 2026
Mar 2, 2026

Get an email when SINT's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Feb 25 – Mar 2
    Christopher Michael Lyons
    Director · bought 8,292 at avg $2.91
    24K
    New position
  • Feb 23
    Jay M Moyes
    Director · bought 1,000 at $2.91
    3K
    33% of stake
  • Feb 18
    Mark Lewis Anderson
    Director · bought 3,000 at $3.02
    9K
    20% of stake
  • Dec 8, 2025
    Gregg R. Honigblum
    Chief Investment Officer · bought 8,200 at avg $4.26
    35K
    4.3% of stake
  • Dec 5, 2025
    Gregg R. Honigblum
    Chief Investment Officer · bought 65,000 at avg $3.93
    255K
    51% of stake
  • Nov 7, 2025
    Gregg R. Honigblum
    Chief Investment Officer · bought 10,000 at avg $3.19
    32K
    16% of stake
  • Oct 20, 2025
    Eric K. Olson
    President and CEO · bought 5,800 at $3.40
    20K
    23% of stake
  • Aug 26, 2025
    Jay M Moyes
    Director · bought 3,000 at $3.59
    11K
    New position
  • Aug 26, 2025
    Gregg R. Honigblum
    Chief Investment Officer · bought 50,000 at avg $3.70
    185K
    357% of stake
  • Aug 22, 2025
    Eric K. Olson
    President and CEO · bought 10,475 at avg $3.58
    37K
    72% of stake
  • Jun 18, 2025
    Mark Lewis Anderson
    Director · bought 10,000 at $3.30
    33K
    200% of stake
  • Apr 24, 2025
    Mark Lewis Anderson
    Director · bought 5,000 at $2.36
    12K
    New position
  • Apr 22, 2025 – Apr 23, 2025
    Eric K. Olson
    President and CEO · bought 14,500 at avg $1.94
    28K
    New position
  • Apr 22, 2025
    Gregg R. Honigblum
    Chief Strategy Officer · bought 4,000 at $1.79
    7K
    40% of stake
  • Apr 22, 2025
    Gregg R. Honigblum
    Chief Strategy Officer · bought 10,000 at avg $1.77
    18K
    New position
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch SINT, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with SINT

CompareIntrinsic value
PLSEPulse Biosciences, Inc.
$57.06+9.31%40
PETVPetvivo Holdings Inc
$0.60+1.69%26
EBRCZEBR Systems, Inc.
$0.08+0.00%0
HRGNHarvard Apparatus Regenerative Technology Inc.
$2.30+0.00%10
ICUSeastar Medical Holding Corporation
$2.04+2.00%20
EMEDElectromedical Technologies Inc.
$0.00+0.00%26
VYCOVycor Medical Inc.
$0.05-3.85%50
OSRHOsr Holdings Inc.
$0.16-5.88%10

Spot a number that looks wrong? Check it in SINT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing SINT

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.